跳至主要内容
临床试验/CTRI/2022/04/042026
CTRI/2022/04/042026已完成2 期

Effects of Individualized Homoeopathic Medicines in Preventing the Progression from Pre-diabetes to Diabetes: A Double-blind, Randomized, Placebo-controlled, Parallelarm Pilot Trial

D N De Homoeopathic Medical College and Hospital0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients having pre-diabetes: HbA1c 5.7-6.4%,
  • fasting blood glucose 100-125 mg/dl, impaired
  • fasting glucose- 140-199 mg/dl (ICD-10 code
  • 2. Age: 18-65 years.
  • 3. Sex: Both Male and Female.
  • 4. Indian Diabetic Risk Score (IDRS) more than 60.
  • 5. Literate patient; ability to read English or
  • 6. Providing with written informed consent

排除标准

  • 1. Patients having diabetes mellitus.
  • 2. Currently undergoing anti-diabetic drug
  • 3. Diagnosed cases of unstable mental or
  • psychiatric illness or other uncontrolled or
  • life-threatening illness affecting quality of
  • life or any vital organ failure.
  • 4. Patients with a habit of tobacco chewing and/
  • or smoking, alcoholism and/or any other
  • form(s) of substance abuse and/or dependence.
  • 5. Vulnerable population: unconscious,ambulatory,
  • too sick for consultation, differently abled,
  • terminally or critically ill patients,
  • mentally incompetent people.
  • 6. Self-reported immune-compromised state.
  • 7. Dyslipidemia: Total cholesterol- more than
  • 199 mg/dl of blood, triglycerides more than
  • 150 mg/dl, LDL more than 100 mg/dl, VLDL more
  • than 150 mg/dl.
  • 8. Serum urea: more than 40 mg/dl of blood and
  • serum creatinine more than 1.2 mg/dl of blood
  • will be excluded.
  • 9. Pregnant and puerperal women and lactating
  • 10. Undergoing homeopathic treatment for any
  • chronic disease within last 6 months.
  • 11. Patients who are too sick for consultation.

研究者

发起方
D N De Homoeopathic Medical College and Hospital

相似试验